Eloralintide
ELORSelective amylin receptor agonist.
Also known as: LY3841136
Overview
Eloralintide is a selective amylin-receptor agonist studied in appetite-regulation and weight-management research as a next-generation amylin analog.
An emerging selective amylin-receptor agonist (Lilly LY3841136) studied for weight management as a potential non-incretin or incretin-complementary option. Early research positions it within the next wave of amylin-pathway obesity candidates.
Selectively activates amylin receptors to modulate satiety and gastric emptying with high receptor selectivity.
Molecular information
Lilly LY3841136 — a selective amylin agonist in early clinical development.
Pharmacokinetics
Illustrative relative-concentration model derived from published pharmacokinetic research. Curve is normalized and provided for educational comparison only — not a dosing schedule.
Research applications
- Amylin-pathway research
- Appetite-regulation studies
- Metabolic investigations
Observed effects timeline
Aggregated observations reported across research literature. Timing and magnitude vary by model and are not a guarantee of outcome.
Early studies
Onset of satiety signaling via amylin-receptor activation reported in early research.
Ongoing
Weight and tolerability endpoints under active clinical investigation.
Research compatibility
Describes how compounds are studied alongside one another in the literature. Not a recommendation to co-administer.
Cagrilintide
Redundant amylin-receptor activity.
GLP-3
Amylin + incretin combinations studied with staggered timing.
GLP-1
Complementary pathways; staggered designs used in research.
How to reconstitute
Reconstitute with bacteriostatic water, swirl gently, and refrigerate. Limited characterization given early-stage status.
- 1Allow the vial to reach room temperature.
- 2Swab the stopper with alcohol and let it air dry.
- 3Add bacteriostatic water slowly down the vial wall.
- 4Swirl gently until dissolved — do not shake.
- 5Refrigerate at 2–8 °C and protect from light.
Quality indicators
White, uniform cake
Lyophilized powder should be a white to off-white cake with no discoloration, filling the base of the vial.
Clear solution after reconstitution
With bacteriostatic water, the solution should turn crystal clear and colorless, with no visible particles.
Slight clumping
Small clumps that dissolve completely with gentle swirling are acceptable — shipping can cause minor compaction.
Collapsed or melted appearance
Powder that looks collapsed, melted, or stuck to the vial walls may have been exposed to heat in transit.
Cloudy after reconstitution
Persistent cloudiness, particles, or precipitate after gentle mixing can indicate a degraded or contaminated peptide.
Reported observations & safety
Safety signals reported in the research literature. Compiled for scientific awareness — not medical advice.
- As an amylin agonist, gastrointestinal effects are the expected predominant signal.
- Human safety and efficacy data are still emerging.
References & further reading
Selective amylin agonists for obesity (review)
Overview of selective amylin-receptor agonists as an emerging class for weight management research.
Topics
This entry is provided for educational and informational purposes only. It is not medical advice, a dosing protocol, or a claim of therapeutic benefit. Research compounds are supplied strictly for laboratory and research use — not for human or veterinary consumption.
Active but early-stage research; evidence still developing.
This compound is part of our educational reference and is not currently stocked. Browse the catalogue for available research-grade peptides.
Browse catalogue